NERVGEN PHARMA CORP. Increase Decrease Through Exercise Of Options
NERVGEN PHARMA CORP. (NGEN) reported Increase Decrease Through Exercise Of Options of CAD 4.48 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions · last filed 2026-03-31
| Period end | Increase Decrease Through Exercise Of Options 12 month |
|---|---|
| 2025-12-31 | 4.48M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 1.28M CAD 40-F · filed 2026-03-31 |